These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26065862)

  • 1. Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.
    Bergin SP; Thaden JT; Ericson JE; Cross H; Messina J; Clark RH; Fowler VG; Benjamin DK; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Sep; 34(9):933-6. PubMed ID: 26065862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants.
    Ericson JE; Thaden J; Cross HR; Clark RH; Fowler VG; Benjamin DK; Cohen-Wolkowiez M; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Apr; 34(4):371-5. PubMed ID: 25760564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
    Cordero L; Rau R; Taylor D; Ayers LW
    Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants.
    Thaden JT; Ericson JE; Cross H; Bergin SP; Messina JA; Fowler VG; Benjamin DK; Clark RH; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Nov; 34(11):1175-9. PubMed ID: 26222060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study.
    MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
    Antimicrob Resist Infect Control; 2021 Sep; 10(1):131. PubMed ID: 34488891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic Susceptibility of Escherichia coli Among Infants Admitted to Neonatal Intensive Care Units Across the US From 2009 to 2017.
    Flannery DD; Akinboyo IC; Mukhopadhyay S; Tribble AC; Song L; Chen F; Li Y; Gerber JS; Puopolo KM
    JAMA Pediatr; 2021 Feb; 175(2):168-175. PubMed ID: 33165599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.
    Tumbarello M; Sali M; Trecarichi EM; Leone F; Rossi M; Fiori B; De Pascale G; D'Inzeo T; Sanguinetti M; Fadda G; Cauda R; Spanu T
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3244-52. PubMed ID: 18591273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal bloodstream infections in a Ghanaian Tertiary Hospital: Are the current antibiotic recommendations adequate?
    Labi AK; Obeng-Nkrumah N; Bjerrum S; Enweronu-Laryea C; Newman MJ
    BMC Infect Dis; 2016 Oct; 16(1):598. PubMed ID: 27776490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ten-year review of ESBL and non-ESBL Escherichia coli bloodstream infections among children at a tertiary referral hospital in South Africa.
    Malande OO; Nuttall J; Pillay V; Bamford C; Eley B
    PLoS One; 2019; 14(9):e0222675. PubMed ID: 31550295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program.
    Cordero L; Sananes M; Ayers LW
    Infect Control Hosp Epidemiol; 1999 Apr; 20(4):242-6. PubMed ID: 10219874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.
    Pascual V; Alonso N; Simó M; Ortiz G; Garcia MC; Xercavins M; Rivera A; Morera MA; Miró E; Espejo E; Navarro F; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1997-2003. PubMed ID: 27549108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.
    Al-Hasan MN; Lahr BD; Eckel-Passow JE; Baddour LM
    J Antimicrob Chemother; 2009 Jul; 64(1):169-74. PubMed ID: 19435736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis.
    Bizzarro MJ; Dembry LM; Baltimore RS; Gallagher PG
    Pediatrics; 2008 Apr; 121(4):689-96. PubMed ID: 18381532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.
    Thom KA; Schweizer ML; Osih RB; McGregor JC; Furuno JP; Perencevich EN; Harris AD
    BMC Infect Dis; 2008 Sep; 8():116. PubMed ID: 18793400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.